Participants in controversial cancer trials have “resolved and settled all claims against” Duke University and oncologist Anil Potti, who previously admitted to fraud, lawyer says.
As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.
Researchers inject retinal support cells derived from human embryonic stem cells into the eyes of four men with macular degeneration, bolstering evidence of the experimental treatment’s safety.
In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.
The largest and longest study of long-term, regular aspirin use finds that the drug may lead to a modestly reduced risk for some types of gastrointestinal cancers.
The World Health Organization again calls upon researchers to register clinical trial details in freely accessible databases before initiation of the study.